ClinicalTrials.gov
ClinicalTrials.gov Menu

The Diagnostic and Prognostic Value of Two Quantitative Clinical Tests in Patients With Lumbar Disc Herniation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03832036
Recruitment Status : Recruiting
First Posted : February 6, 2019
Last Update Posted : February 6, 2019
Sponsor:
Collaborators:
The Parker Institute, Frederiksberg Hospital, Denmmark
Center for Rheumatology and Spine Diseases, Frederiksberg Hospital, Denmark
Department of Neurology, Odense University Hospital, Denmark
Department of Neurosurgery, Odense University Hospital, Denmark
Information provided by (Responsible Party):
Spine Centre of Southern Denmark

Brief Summary:

This study will investigate whether two clinical tests can be used to diagnose and predict the outcome in patients with lumbar disc herniation undergoing surgery and non-surgery treatment.

The two quantitative clinical tests include: electromyographic measurements using Paraspinal Mapping and pain responses using Quantitative Sensory Pain Testing.


Condition or disease Intervention/treatment Phase
Pain Lumbar Disc Herniation Back Pain Spinal Diseases Surgery Diagnostic Test: Paraspinal Mapping and Quantitative Sensory Pain Test Not Applicable

Detailed Description:
150 patients will be included for the prospective cohort study. Patients will be recruited from the Region of Southern Denmark and Capital Region. Participants will undergo MRI scanning of the lumbar spine, fillout a questionnaire and undergo assessment with the two clinical tests. An 8-week follow-up will be made with patients completing a questionnaire. The two quantitative clinical tests include: electromyographic measurements using Paraspinal Mapping and pain responses using Quantitative Sensory Pain Testing.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 150 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: The Diagnostic and Prognostic Value of Two Quantitative Clinical Tests in Patients
Actual Study Start Date : October 1, 2018
Estimated Primary Completion Date : October 2019
Estimated Study Completion Date : November 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Hernia

Arm Intervention/treatment
Experimental: Patients with lumbar disc herniation Diagnostic Test: Paraspinal Mapping and Quantitative Sensory Pain Test
Participants will be tested at baseline.




Primary Outcome Measures :
  1. The diagnostic value of Paraspinal Mapping and Quantitative Sensory Pain Testing [ Time Frame: 8 week follow-up ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Clinical and radiologically diagnosed lumbar disc herniation.
  • Low back pain with pain below the knee or anterior thigh pain in one or both legs.
  • Dermatomal leg pain.
  • Average pain intensity of 3 or more on a Numerical Rating Scale (0-10 NRS).

Exclusion Criteria:

  • History of previous lumbar spine surgery.
  • Surgery in general in the past 4 months.
  • Current use of anticoagulants.
  • Diagnoses which could confound with the diagnosis e.g. lumbar spinal stenosis, local muscle trauma, cancer metastases, fibromyalgia, neuropathy.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03832036


Contacts
Contact: Johanne B Filtenborg, M.Sc. +4538164167 johanne.brinch.larsen@rsyd.dk

Locations
Denmark
Center for Rheumatology and Spine Diseases, Frederiksberg Hospital. Recruiting
Frederiksberg, Denmark, 2000
Contact: Johanne B Filtenborg, M.Sc.         
Sponsors and Collaborators
Spine Centre of Southern Denmark
The Parker Institute, Frederiksberg Hospital, Denmmark
Center for Rheumatology and Spine Diseases, Frederiksberg Hospital, Denmark
Department of Neurology, Odense University Hospital, Denmark
Department of Neurosurgery, Odense University Hospital, Denmark
Investigators
Principal Investigator: Johanne B Filtenborg, M.Sc. Spine Centre Southern Denmark
Study Director: Berit Schiøttz-Christensen, MD Spine Centre Southern Denmark
Study Chair: Søren O'Neill, DC Spine Centre Southern Denmark
Study Chair: Kirstine Amris, MD The Parker Institute, Frederiksberg Hospital
Study Chair: Gilles Fournier, MD, DC Center for Rheumatology and Spine Diseases, Frederiksberg Hospital
Study Chair: Andrew J Haig, MD University of Michigan

Responsible Party: Spine Centre of Southern Denmark
ClinicalTrials.gov Identifier: NCT03832036     History of Changes
Other Study ID Numbers: 201170138
First Posted: February 6, 2019    Key Record Dates
Last Update Posted: February 6, 2019
Last Verified: February 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Spine Centre of Southern Denmark:
Electromyography
Paraspinal Mapping
Quantitative clinical tests
Conditioned pain modulation
Temporal pain summation
Pain threshold
Pain tolerance

Additional relevant MeSH terms:
Back Pain
Hernia
Spinal Diseases
Pain
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Pathological Conditions, Anatomical
Bone Diseases
Musculoskeletal Diseases